StonvexLoading…
StonvexStonvexStonvexCore line items from OPAL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $87.63M | $67.42M | $326.72M | $238.30M | $160.41M |
Operating Income | Not available | $-4.84M | $7.41M | $819.00K | $-2.77M |
Net Income | Not available | $-5.59M | $36.41M | $20.23M | $8.84M |
EPS (Diluted) | $-0.02 | $-0.09 | $0.15 | $0.07 | $0.02 |
Total Assets | Not available | $1.06B | $959.47M | $916.75M | $905.54M |
Total Liabilities | Not available | $548.71M | $461.71M | $433.95M | $432.29M |
Cash & Equivalents | Not available | $133.24M | $24.41M | $29.93M | $29.27M |
Free Cash Flow OCF − CapEx | Not available | $-11.45M | $-34.24M | $-20.87M | $-11.60M |
Shares Outstanding | Not available | 28.30M | 29.25M | 29.01M | 28.69M |